Published: Guidance, quality standards and advice
Showing 1 to 10 of 12
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Remdesivir and tixagevimab plus cilgavimab for treating COVID-19 | TA971 | ||
| COVID-19 rapid guideline: managing COVID-19 | NG191 | ||
| Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19 | TA878 | ||
| COVID-19 rapid guideline: managing the long-term effects of COVID-19 | NG188 | ||
| COVID-19 rapid guideline: haematopoietic stem cell transplantation | NG164 | ||
| Tixagevimab plus cilgavimab for preventing COVID-19 | TA900 | ||
| Butterfly iQ+ for diagnostic ultrasound imaging | MIB254 | ||
| URO17 for detecting bladder cancer | MIB250 | ||
| FebriDx for C-reactive protein and myxovirus resistance protein A testing | MIB224 | ||
| CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic | MIB219 |